Alison D Grant Selected Research

Isoniazid (Ftivazide)

10/2021	Annual Tuberculosis Preventive Therapy for Persons With HIV Infection : A Randomized Trial.
6/2020	Predictors of silicosis and variation in prevalence across mines among employed gold miners in South Africa.
11/2016	Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.
3/2016	The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.
4/2015	Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.
4/2014	Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings.
1/2014	A trial of mass isoniazid preventive therapy for tuberculosis control.
1/2014	A trial of mass isoniazid preventive therapy for tuberculosis control.
1/2013	Eligibility for isoniazid preventive therapy in South African gold mines.
6/2012	Undiagnosed tuberculosis among HIV clinic attendees: association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison D Grant Research Topics

Disease

54	Tuberculosis (Tuberculoses) 01/2022 - 09/2003
10	Infections 03/2022 - 06/2002
8	HIV Infections (HIV Infection) 10/2021 - 06/2002
4	Anemia 01/2021 - 01/2008
3	Silicosis 01/2022 - 06/2005
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 08/2021 - 01/2020
3	Malaria 07/2010 - 01/2004
2	Viremia 01/2011 - 12/2009
2	Hepatitis B 12/2008 - 06/2007
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2008 - 06/2002
1	Sudden Death 08/2021
1	Hypertension (High Blood Pressure) 08/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2021
1	Noncommunicable Diseases 01/2021
1	Ataxia (Dyssynergia) 01/2020
1	Extensively Drug-Resistant Tuberculosis 01/2020
1	Chronic Disease (Chronic Diseases) 05/2015
1	Latent Infection 04/2014
1	Reinfection 04/2014
1	Latent Tuberculosis 01/2014
1	Pulmonary Tuberculosis 04/2012
1	Silicotuberculosis 05/2011
1	Coinfection 12/2008
1	Chronic Hepatitis B 12/2008
1	Kaposi Sarcoma (Kaposi's Sarcoma) 02/2008
1	Neutropenia 01/2008
1	Nausea 01/2008
1	Exanthema (Rash) 01/2008
1	Vomiting 01/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2008
1	Dizziness (Lightheadedness) 01/2008

Drug/Important Bio-Agent (IBA)

21	Isoniazid (Ftivazide)FDA LinkGeneric 10/2021 - 06/2005
18	GoldIBA 01/2022 - 09/2003
8	Pharmaceutical PreparationsIBA 10/2021 - 12/2009
4	lipoarabinomannan (LAM)IBA 01/2020 - 01/2015
3	Tuberculin (PPD)IBA 01/2022 - 11/2003
3	bedaquiline (R207910)IBA 08/2021 - 01/2020
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 02/2008
2	VaccinesIBA 12/2017 - 06/2002
2	RNA (Ribonucleic Acid)IBA 11/2011 - 12/2009
1	C-Reactive ProteinIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	rifapentine (Priftin)FDA Link 10/2021
1	AzolesIBA 08/2021
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2021
1	InterferonsIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Clofazimine (Lamprene)FDA Link 01/2020
1	AntigensIBA 01/2015
1	Indicators and Reagents (Reagents)IBA 04/2012
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2012
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2010
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 07/2010
1	Reverse Transcriptase InhibitorsIBA 12/2009
1	NucleosidesIBA 12/2009
1	Oxygen (Dioxygen)IBA 02/2008
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2007
1	insulin receptor-related receptor (IRR)IBA 06/2005
1	Antimalarials (Antimalarial Agents)IBA 01/2004
1	Proguanil (Paludrine)FDA Link 01/2004
1	Mefloquine (Lariam)FDA LinkGeneric 01/2004
1	Chloroquine (Aralen)FDA LinkGeneric 01/2004
1	AIDS VaccinesIBA 06/2002

Therapy/Procedure

35	Therapeutics 10/2021 - 09/2003
9	Art Therapy 01/2020 - 12/2008
4	Highly Active Antiretroviral Therapy (HAART) 05/2015 - 01/2008
1	Personal Protective Equipment 03/2022
1	Inappropriate Prescribing 01/2021
1	Treatment Delay 04/2015
1	Insecticide-Treated Bednets 12/2004